Savara SVRA Enterprise value

Enterprise value at other companies

XER

Xeris Biopharma Holdings, Inc.XERS

$1.54B+62.6%

Innoviva, Inc.INVA

$1.38B+1.8%

Zevra Therapeutics, Inc.ZVRA

$703.89M+36.7%

Upstream Bio, Inc.UPB

$394.17M+52.4%

ANI PharmaceuticalsANIP

$1.82B+17.9%

PVL

Palvella TherapeuticsPVLA

$1.58B—

FAQ

What is Savara's enterprise value?

Savara (SVRA) reported enterprise value of $1.11B in Q1 2026.

How has Savara's enterprise value changed year-over-year?

Savara's enterprise value increased by 127.1% year-over-year, from $488.16M to $1.11B.

What is the long-term trend for Savara's enterprise value?

Over 5 years (2020 to 2025), Savara's enterprise value has grown at a 68.2% compound annual growth rate (CAGR), from $91.02M to $1.22B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.